Key Takeaways
- HubSpot shares plummeted over 24% during Friday’s premarket session following first-quarter earnings release
- Q1 revenue reached $881M, surpassing expectations, yet annual projections underwhelmed investors
- Cantor Fitzgerald and William Blair issued downgrades following the earnings report
- Extended sales cycles and internal sales team retraining impacted forward-looking projections
- Morgan Stanley reduced its target price from $405 down to $350 while keeping an Overweight stance
HubSpot (HUBS) experienced a dramatic decline of more than 24% during Friday’s premarket session, beginning the day at $243.74, following an earnings report that left investors questioning whether the company can achieve the ambitious growth projections the market had anticipated.
The first-quarter results themselves were impressive. The company posted $881 million in revenue, representing a 23% year-over-year increase and exceeding the consensus forecast of $863 million. Earnings per share reached $2.72, outperforming analyst predictions of $2.47 by $0.25. The operating margin came in at 17.8%, exceeding expectations by 100 basis points.
The real issue? Forward-looking projections.
The company’s annual revenue forecast didn’t adequately incorporate the first-quarter success. Analysts at Cantor Fitzgerald observed that management only channeled approximately two-thirds of the Q1 outperformance into the FY26 projections. This means the high-teens to approximately 20% constant-currency growth rate that many market participants had been anticipating now appears unattainable.
Cantor Fitzgerald downgraded its rating from Overweight to Neutral and dramatically reduced its price objective from $325 down to $200. William Blair similarly shifted its stance to Market Perform from Outperform.
Internal Sales Team Changes Created Additional Headwinds
Compounding matters was a setback during the opening weeks of Q2. The company dedicated roughly one week in April to retraining its entire sales organization following modifications related to its Spring Spotlight product rollout. This interruption negatively impacted momentum at the beginning of the second quarter.
Executive leadership also highlighted lengthening sales cycles as a concern. Cantor Fitzgerald’s research team characterized many of these challenges as “self-inflicted choices” implemented with long-term strategic advantages in mind, though they’re expected to suppress growth throughout the coming quarters.
Morgan Stanley maintained its Overweight recommendation but lowered its price objective from $405 to $350. Additional firms including Wells Fargo, Needham, Stifel, and Citigroup also reduced their targets. Needham implemented the most aggressive adjustment, dropping from $700 to $300 while preserving a Buy recommendation.
Current Analyst Sentiment
Overall, Wall Street’s outlook remains moderately optimistic. Among the 29 analysts monitored by MarketBeat, 23 recommend buying the stock, four suggest holding, and two advise selling. The mean price target currently stands at $365.96 — substantially higher than current trading levels.
The stock reached a 52-week peak of $682.57. During the same timeframe, it touched a low of $187.45.
For the second quarter of 2026, management projects EPS between $3.00 and $3.02. Annual EPS guidance ranges from $13.04 to $13.12.
Insider transactions have drawn attention recently. Board member Brian Halligan divested 8,500 shares during March at $262.75 per share. Insider Erika Ashley Fisher sold 915 shares on May 4th at $236.66, with the transaction related to tax liabilities from equity compensation vesting.
Regarding institutional ownership, T. Rowe Price expanded its holdings by 36.5% in the fourth quarter, while AQR Capital Management increased its position by 117.6%. Institutional investors collectively control 90.39% of outstanding shares.
HUBS currently maintains a market capitalization of $12.55 billion with a price-to-earnings ratio of 280.16.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
